IJRvsLABD
iShares Core S&P Small-Cap ETF against DIREXION DAILY S&P BIOTECH BEAR 3X SHARES — the fee, the flows, the book, and a year head-to-head.
Head to head
| IJR | LABD | |
|---|---|---|
| Expense ratio | 0.060% | — |
| Assets | $104B | $78M |
| Net flow, 1 month | −$963M | −$80M |
| Net flow, 1 year | +$3.4B | +$73M |
| Return, YTD | +16.2% | -66.1% |
| Return, 1 year | +15.3% | -75.3% |
| Avg daily volume | 3.6M | 25.4M |
| Holdings | 688 | 1 |
| Listed | May 22, 2000 | Jul 31, 2024 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS